搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
6 小时
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical ...
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized ...
verywellhealth
20 小时
What Are Risk Factors for Diabetic Kidney Disease?
The kidneys are two fist-sized, bean-shaped organs located on either side of the spine. Their main purpose is to ... which returns about 99% of the water in your blood back into the circulation system ...
Science Friday
4 天
The Chicken-And-Egg Problem Of The Origin Of Life
In a new book, astrophysicist Mario Livio describes how the existence of life on Earth can be traced back to an RNA-based ...
Chemistry World
4 天
US approves schizophrenia drug with new mode of action
The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...
4 天
on MSN
Guelph man hits 'roadblock' in bid to clean up roadside trash along 2-km stretch of Highway 401
Wayne Fernandes is frustrated he's hit a “roadblock” with the Ontario Ministry of Transportation in his attempt to get ...
The Healthy on MSN
8 天
12 Memory Problems that Look Like Alzheimer’s—But Aren’t
Memory lapses aren't always caused by Alzheimer's. Depression, infections or even vitamin deficiencies may be the reason. The ...
Calgary Herald
9 天
Nieman: New technology aids in diagnosis and medication treatment
It is often a challenge to find the right medication for children with neurological concerns such as ADHD, autism (ASD), ...
Pharmaceutical Technology
10 天
BMS wins approval for schizophrenia drug acquired from Karuna
The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.
Medscape
10 天
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈